Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1 [Retraction]

OncoTargets and Therapy

卷:Volume 14

关键词: hepatocellular carcinoma;    exosome;    mir-638;    sp1;   

DOI  :  

来源: DOAJ

【 摘 要 】

Yang J, Li B, Zhao S, Du H, Du Y. Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1. Onco Targets Ther. 2020;13:6709–6720.At the request of the author, the Editor and Publisher of OncoTargets and Therapy wish to retract the published paper.Following a review of their paper the authors have determined that due to a lack of data they can no longer confirm this study showed an anti-cancer role of exosome miR-638 in hepatocellular carcinoma (HCC) by inhibiting angiogenesis. The authors also confirmed they could no longer locate the original data for this study. In the interests of scientific integrity, the authors have agreed it best to retract the published article.This retraction relates to this paper

【 授权许可】

Unknown